• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性甲状腺髓样癌:一例报告。

Metastatic medullary thyroid carcinoma: A case report.

作者信息

Niafar Mitra, Dabiri Shahram, Bozorgi Farshid, Niafar Farid, Gholami Nasrin

机构信息

Assistant Professor, Endocrinology and Metabolism Section, Department of Medicine, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

J Res Med Sci. 2011 Apr;16(4):568-73.

PMID:22091276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3214365/
Abstract

Medullary thyroid carcinoma accounts for 4% of thyroid carcinoma and originates from parafollicular cells, secreting calcitonin and carcinoembryonic antigen (CEA). Conventional radiographic modalities such as Computerized Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasonography (U/S), are used for detecting recurrences following total thyroidectomy. However, metastatic disease frequently escapes detection by the above modalities, even when its presence is suggested by persistently elevated serum calcitonin levels. In this paper, we report a case of medullary thyroid carcinoma in a 40 year-old woman who had whole body octreotide scintigraphy to evaluate and detect the origin of calcitonin and CEA secretion.

摘要

甲状腺髓样癌占甲状腺癌的4%,起源于滤泡旁细胞,分泌降钙素和癌胚抗原(CEA)。传统的影像学检查方法,如计算机断层扫描(CT)、磁共振成像(MRI)和超声检查(U/S),用于检测甲状腺全切除术后的复发情况。然而,即使血清降钙素水平持续升高提示转移灶的存在,转移病灶仍常无法通过上述检查方法被发现。在本文中,我们报告了一例40岁女性甲状腺髓样癌患者,该患者接受了全身奥曲肽闪烁扫描,以评估和检测降钙素及CEA分泌的来源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5913/3214365/4a87dc518e0c/JRMS-16-568-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5913/3214365/81054d9b2c61/JRMS-16-568-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5913/3214365/6aeae5a54f7b/JRMS-16-568-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5913/3214365/0781efb0001e/JRMS-16-568-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5913/3214365/807da2bc04c4/JRMS-16-568-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5913/3214365/84a480b4de7d/JRMS-16-568-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5913/3214365/4a87dc518e0c/JRMS-16-568-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5913/3214365/81054d9b2c61/JRMS-16-568-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5913/3214365/6aeae5a54f7b/JRMS-16-568-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5913/3214365/0781efb0001e/JRMS-16-568-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5913/3214365/807da2bc04c4/JRMS-16-568-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5913/3214365/84a480b4de7d/JRMS-16-568-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5913/3214365/4a87dc518e0c/JRMS-16-568-g006.jpg

相似文献

1
Metastatic medullary thyroid carcinoma: A case report.转移性甲状腺髓样癌:一例报告。
J Res Med Sci. 2011 Apr;16(4):568-73.
2
Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?抗癌胚抗原抗体与生长抑素类似物在检测转移性甲状腺髓样癌中的比较:癌胚抗原和生长抑素受体表达是预后因素吗?
Cancer. 1997 Dec 15;80(12 Suppl):2436-57. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2436::aid-cncr16>3.3.co;2-3.
3
Uncovering the Uncommon: An 81-Year-Old Woman With Elevated Carcinoembryonic Antigen (CEA) but Normal Calcitonin Levels Diagnosed With Medullary Thyroid Carcinoma.发现罕见病例:一名81岁女性癌胚抗原(CEA)升高但降钙素水平正常,被诊断为甲状腺髓样癌。
Cureus. 2023 Jun 12;15(6):e40290. doi: 10.7759/cureus.40290. eCollection 2023 Jun.
4
Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.降钙素和 CEA 双阴性甲状腺髓样癌 1 例报告及文献复习
BMC Endocr Disord. 2019 Oct 16;19(1):103. doi: 10.1186/s12902-019-0435-7.
5
Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery.术后肿瘤标志物水平升高患者中,铟-111奥曲肽与锝-99m(V)二巯基丁二酸闪烁扫描术检测甲状腺髓样肿瘤病灶的比较
Clin Nucl Med. 2001 Aug;26(8):683-8. doi: 10.1097/00003072-200108000-00004.
6
F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.F-18-多巴正电子发射断层扫描/计算机断层扫描比全身磁共振成像更敏感,可用于定位持续性/复发性甲状腺髓样癌患者的疾病。
Thyroid. 2019 Oct;29(10):1457-1464. doi: 10.1089/thy.2018.0351.
7
Positron emission tomography (18FDG-PET) in the detection of medullary thyroid carcinoma metastases.正电子发射断层扫描(18氟脱氧葡萄糖正电子发射断层扫描,18FDG-PET)在检测甲状腺髓样癌转移灶中的应用
Endokrynol Pol. 2006 Jul-Aug;57(4):452-5.
8
Case Report: A Challenging Clinical Problem of Calcitonin-Negative Medullary Thyroid Cancer Diagnosis and Surveillance.病例报告:降钙素阴性甲状腺髓样癌诊断与监测中的一个具有挑战性的临床问题。
Cureus. 2022 Nov 30;14(11):e32088. doi: 10.7759/cureus.32088. eCollection 2022 Nov.
9
Somatostatin receptor imaging in persistent medullary thyroid carcinoma.
Clin Endocrinol (Oxf). 1995 Jan;42(1):31-7. doi: 10.1111/j.1365-2265.1995.tb02595.x.
10
Radioguided hepatic resection with F-DOPA in a patient with metastatic medullary thyroid carcinoma.放射性引导下使用F-DOPA对转移性甲状腺髓样癌患者进行肝切除术。
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Jul-Aug;37(4):244-249. doi: 10.1016/j.remn.2017.12.003. Epub 2018 May 10.

引用本文的文献

1
Management of medullary thyroid cancer based on variation of carcinoembryonic antigen and calcitonin.基于癌胚抗原和降钙素变化的甲状腺髓样癌的管理。
Front Endocrinol (Lausanne). 2024 Oct 10;15:1418657. doi: 10.3389/fendo.2024.1418657. eCollection 2024.
2
Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes.阿德福韦酯作为甲状腺髓样癌的治疗候选药物:靶向RET和STAT3原癌基因
Cancers (Basel). 2023 Apr 5;15(7):2163. doi: 10.3390/cancers15072163.
3
No calcitonin change in a person taking dulaglutide diagnosed with pre-existing medullary thyroid cancer.

本文引用的文献

1
Medullary thyroid cancer: management guidelines of the American Thyroid Association.甲状腺髓样癌:美国甲状腺协会管理指南
Thyroid. 2009 Jun;19(6):565-612. doi: 10.1089/thy.2008.0403.
2
Medullary thyroid cancer: monitoring and therapy.甲状腺髓样癌:监测与治疗
Endocrinol Metab Clin North Am. 2007 Sep;36(3):823-37, viii. doi: 10.1016/j.ecl.2007.04.001.
3
Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma.使用99mTc-EDDA/HYNIC-TOC对甲状腺髓样癌患者进行生长抑素受体闪烁显像。
使用度拉糖肽的患者,若患有既往存在的甲状腺髓样癌,则降钙素无变化。
Diabet Med. 2018 Mar;35(3):381-385. doi: 10.1111/dme.13437.
4
Cabozantinib for the treatment of metastatic medullary thyroid carcinoma.卡博替尼用于治疗转移性甲状腺髓样癌。
J Adv Pract Oncol. 2014 Jan;5(1):47-50. doi: 10.6004/jadpro.2014.5.1.10.
Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1635-45. doi: 10.1007/s00259-007-0479-1. Epub 2007 May 26.
4
Medullary thyroid cancer: options for systemic therapy of metastatic disease?甲状腺髓样癌:转移性疾病的全身治疗选择?
J Clin Oncol. 2006 Apr 10;24(11):1653-5. doi: 10.1200/JCO.2005.05.4106. Epub 2006 Mar 20.
5
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.BAY 43 - 9006具有广谱口服抗肿瘤活性,作用于参与肿瘤进展和血管生成的RAF/MEK/ERK信号通路及受体酪氨酸激酶。
Cancer Res. 2004 Oct 1;64(19):7099-109. doi: 10.1158/0008-5472.CAN-04-1443.
6
99mTc-EDDA/HYNIC-TOC in the management of medullary thyroid carcinoma.99mTc-乙二胺二乙酸/高锝[99mTc]亚氨基乙酰基-奥曲肽在甲状腺髓样癌治疗中的应用
Cancer Biother Radiopharm. 2004 Apr;19(2):211-7. doi: 10.1089/108497804323071995.
7
Postoperative calcitonin study in medullary thyroid carcinoma.甲状腺髓样癌术后降钙素研究
Endocr Relat Cancer. 2004 Jun;11(2):357-63. doi: 10.1677/erc.0.0110357.
8
An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.99mTc-EDDA/HYNIC-TOC与111In-DTPA-奥曲肽用于诊断生长抑素受体表达肿瘤的患者内比较
J Nucl Med. 2003 May;44(5):708-16.
9
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases.ZD6474是一种口服可用的KDR酪氨酸激酶活性抑制剂,能有效阻断致癌性RET激酶。
Cancer Res. 2002 Dec 15;62(24):7284-90.
10
Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination.通过树突状细胞疫苗接种对甲状腺髓样癌进行免疫治疗。
J Clin Endocrinol Metab. 2001 Oct;86(10):4965-9. doi: 10.1210/jcem.86.10.7949.